Mode
Text Size
Log in / Sign up

Network meta-analysis shows image-enhanced endoscopy methods improve adenoma detection rates compared to high-definition white light imaging in colorectal lesion screeningNew Camera Tech Finds More Colon Cancer Clues

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider TXI or LCI for adenoma detection, but interpret lesion characterization findings cautiously due to limited trial data.

This study is a network meta-analysis of randomized controlled trials conducted across various settings, encompassing a total population of 28,663 participants. The analysis focused on the use of image-enhanced endoscopy (IEE) methods for the detection of colorectal lesions. The primary comparator was high-definition white light imaging (HD-WLI). The IEE methods evaluated included texture and color enhancement imaging (TXI), linked color imaging (LCI), high-definition white light imaging (HD-WLI) as a baseline, new-generation narrow band imaging (NBI), and blue light imaging. The primary outcomes assessed were the adenoma detection rate (ADR) and the advanced adenoma detection rate. Secondary outcomes included polyp detection rate, sessile serrated lesion detection rate, the mean number of colonic lesions detected per patient, and lesion characterization accuracy measured by area under the curve (AUC).

The results indicated that TXI ranked highest for the adenoma detection rate, with a relative risk (RR) of 1.48 compared to HD-WLI. The 95% confidence interval for this finding was 1.09 to 2.02. When LCI was compared with HD-WLI, it also showed superiority with an RR of 1.23. Regarding advanced adenoma detection, both TXI and LCI demonstrated superiority over HD-WLI, with RRs of 1.42 and 1.23, respectively. In terms of the number of adenomas detected, new-generation NBI ranked highest with a SUCRA value of 82.3%. For overall polyp detection, LCI led with a SUCRA value of 88.4%.

Lesion characterization results showed that new-generation NBI and blue light imaging effectively distinguished adenomas from non-neoplastic lesions. The AUC for new-generation NBI was 0.880, while the AUC for blue light imaging was 0.812. Safety and tolerability data were not reported in the included trials, and no adverse events, serious adverse events, discontinuations, or specific tolerability metrics were available for analysis. The study did not report specific absolute numbers for adverse events or discontinuations.

When comparing these results to prior landmark studies in the therapeutic area of colorectal cancer screening, this network meta-analysis provides a comprehensive ranking of various IEE modalities. The data suggests that specific IEE techniques offer distinct advantages for detecting adenomas and advanced adenomas compared to standard HD-WLI. However, the study highlights that further comparative studies are needed to guide optimal IEE modality selection for colorectal neoplasia, as the evidence varies by specific outcome and modality.

Key methodological limitations include the fact that findings on lesion characterization are based on a limited number of randomized controlled trials. Consequently, these specific findings should be interpreted cautiously. Potential biases related to the heterogeneity of the included trials and the varying definitions of outcomes across studies may influence the overall conclusions. The study notes that the evidence for lesion characterization is particularly weak and requires careful consideration before clinical application.

Clinically, this evidence supports the consideration of TXI and LCI for improving adenoma and advanced adenoma detection rates in patients undergoing colonoscopy. The choice of IEE modality may depend on the specific clinical goal, such as maximizing polyp detection or optimizing lesion characterization. However, practitioners must recognize that the data for lesion characterization is limited. Questions remain regarding the long-term impact of these detection rates on cancer incidence and mortality, as well as the cost-effectiveness of adopting specific IEE technologies over standard HD-WLI.

In summary, while IEE methods generally outperform HD-WLI for adenoma detection, the evidence is not uniform across all modalities or outcomes. Clinicians should interpret the lesion characterization findings with caution due to the small number of contributing trials. The overall certainty of the evidence for lesion characterization is low, and further research is required to solidify recommendations for routine use of specific IEE technologies in colorectal screening programs.

Imagine walking into a doctor's office for a routine checkup. You are nervous about the scope, hoping the doctor will find everything quickly. Now imagine that doctor has a special camera that makes hidden spots pop out like bright lights in the dark. This is the promise of new imaging technology for colonoscopies.

Colon cancer is a serious disease, but we can stop it early. The best way to stop it is to find and remove small growths called polyps before they turn into cancer. Doctors use a camera called a colonoscope to look inside your colon.

For years, doctors used standard white light to see things. But sometimes, small polyps blend in with the normal tissue. They look like the background. This means they can be missed. Missing a polyp is risky because it could grow into cancer later.

The surprising shift

Researchers wanted to know which special camera settings work best. They looked at many different types of image-enhanced endoscopy. These tools use special lights or filters to make polyps stand out.

But here is the twist. Not all the fancy cameras are equal. Some are better at finding small spots. Others are better at telling the difference between a harmless bump and a dangerous one. This study compared them all to see who wins.

What scientists didn't expect

The team found that texture and color enhancement imaging was the top performer. Think of this like putting a filter on your phone camera. It changes how colors and shadows look. This helps the doctor see the surface of a polyp much better.

Another top tool was linked color imaging. This method uses a special light to highlight blood vessels. It is great for finding all kinds of polyps, not just the big scary ones.

To understand this, think of a busy street. In normal light, a red car might get lost in a crowd of other cars. Now, imagine a traffic camera that only shows red cars. Suddenly, the red car is easy to spot.

That is what these cameras do. They change the way light hits the tissue. Some tools make the blood vessels glow. Others make the texture of the lining look rough or smooth. This helps the doctor spot problems that would otherwise hide in plain sight.

This big study looked at 54 different trials. These trials involved nearly 29,000 people. The doctors used various camera settings during the procedures. They counted how many polyps each camera found. They also checked how well the cameras told the difference between bad and good growths.

The results were clear. The texture and color enhancement tool found the most adenomas. An adenoma is a type of polyp that can become cancer. This tool was 48% better than the standard white light camera.

For finding advanced adenomas, which are closer to cancer, the same tool was also the best. It found these dangerous spots much more often than the old standard.

This doesn't mean this treatment is available yet.

It is important to remember that this is still research. These tools are being tested to make sure they are safe and effective for everyone.

The catch

There is a catch. While the new tools are better at finding polyps, they are not perfect. Some studies had a small number of people. This means we need more data to be sure. Also, these cameras require special training. Doctors must learn how to use them properly to get the best results.

If you are scheduled for a colonoscopy, ask your doctor about the equipment they use. Some hospitals have these new image-enhanced cameras. They can help your doctor see more clearly.

You should talk to your doctor about your risk factors. If you have a family history of colon cancer, you might need a colonoscopy sooner. Knowing what technology is available can help you feel more confident about the procedure.

More research is needed to guide doctors on which tool to use. Scientists will continue to test these cameras. The goal is to make sure every patient gets the best possible care. As more data comes in, we will know exactly which camera works best for different types of polyps.

Study Details

Study typeMeta analysis
Sample sizen = 28,663
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: Different image-enhanced endoscopy (IEE) methods have shown promise in improving colorectal lesion detection, but direct comparisons remain limited. This network meta-analysis compared the detection and diagnostic performance of various IEE modalities for colorectal lesions. METHODS: We searched PubMed, Embase, and Cochrane Library for randomized controlled trials (RCTs) up to May 31, 2025. Primary outcomes included adenoma (adenoma detection rate [ADR]) and advanced ADR; secondary outcomes included polyp (polyp detection rate), sessile serrated lesion detection rate, and mean number of colonic lesions detected per patient. Surface Under the Cumulative Ranking Curve (SUCRA) and pairwise risk ratios (RRs) with 95% confidence intervals (CI) were used. Lesion characterization was evaluated by the summary receiver operating characteristic area under the curve (AUC). RESULTS: In total, 54 RCTs with 28,663 participants were included. Regarding ADR, texture and color enhancement imaging (TXI) ranked highest (SUCRA: 88.4; RR: 1.48, 95% CI: 1.09-2.02), followed by linked color imaging (LCI) when compared with high-definition white light imaging (HD-WLI). For advanced adenoma detection, both TXI (RR: 1.42) and LCI (RR: 1.23) showed superiority over HD-WLI. New-generation narrow band imaging (NBI) ranked highest for the number of adenomas detected (SUCRA: 82.3%), and LCI led in polyps (SUCRA: 88.4%). For lesion characterization, new-generation NBI (AUC: 0.880) and blue light imaging (AUC: 0.812) effectively distinguished adenomas from non-neoplastic lesions. However, this finding is based on a limited number of RCTs and should be interpreted cautiously. DISCUSSION: Our findings indicate TXI and LCI may provide improved detection performance compared with conventional imaging. Blue light imaging and new-generation NBI seem to enhance lesion characterization. Further comparative studies are needed to guide optimal IEE modality selection for colorectal neoplasia.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.